P2-104: Role of ERCC1, XRCC3, Aurora A and TGFBR1 single nucleotide polymorphisms (SNP) and CHFR and 14-3-3 sigma methylation in a customized cisplatin (cis) trial based on ERCC1 mRNA levels in stage IV non-small-cell lung cancer (NSCLC) patients (p)
2007 ◽
Vol 2
(8)
◽
pp. S532-S533
Keyword(s):
Stage Iv
◽
2012 ◽
Vol 17
(12)
◽
pp. 1484-1485
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 7031-7031
2004 ◽
Vol 22
(14_suppl)
◽
pp. 7031-7031
2018 ◽
Vol 10
(3)
◽
pp. 1635-1647
◽
2019 ◽
Vol 781
◽
pp. 63-70
◽
2016 ◽
Vol 96
(2)
◽
pp. S156-S157
2014 ◽
Vol 32
(15_suppl)
◽
pp. 11046-11046
◽